Risk Assessment & Management Flashcards
7 cards from real CMC practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Risk Assessment & Management flashcards as text
A patient presenting with chest pain has a HEART score of 7. What is the recommended management course?
Answer: Admit and consider early invasive strategy
A HEART score of 7–10 indicates high risk for MACE (>65% event rate), necessitating admission and consideration of early invasive evaluation.
Which finding on a dobutamine stress echocardiogram is considered a high-risk marker predicting adverse cardiac outcomes?
Answer: New wall motion abnormality in ≥ 3 segments at low dose dobutamine
Inducible wall motion abnormalities in ≥ 3 segments at low dobutamine doses indicate extensive ischemia and are a high-risk marker associated with adverse outcomes.
In chronic kidney disease (CKD) stage 3b, how does the estimated GFR impact cardiovascular risk stratification?
Answer: CKD stage 3b (eGFR 30–44) is a risk-enhancing factor that raises ASCVD risk
CKD stage 3b (eGFR 30–44 mL/min/1.73m²) is a recognized risk-enhancing factor in 2018 ACC/AHA guidelines, increasing baseline ASCVD risk estimate.
A 58-year-old man with known CAD and recent PCI is prescribed dual antiplatelet therapy (DAPT). Which DAPT score component indicates a patient who benefits more from prolonged DAPT beyond 12 months?
Answer: Prior MI or prior PCI
Prior MI or prior PCI is a positive scoring component in the DAPT Score, indicating patients who may benefit from prolonged dual antiplatelet therapy beyond 12 months post-PCI.
In the management of hypertensive emergency with acute aortic dissection, what is the primary blood pressure target and preferred agent class?
Answer: SBP < 120 mmHg and HR < 60 bpm using IV beta-blockers first
For aortic dissection, IV beta-blockers (e.g., esmolol) are first-line to reduce HR < 60 bpm and SBP to 100–120 mmHg to minimize aortic wall shear stress.
A 65-year-old woman with HFrEF (EF 30%) and LBBB has a QRS duration of 158 ms despite optimal medical therapy. What device therapy is indicated for risk reduction?
Answer: Cardiac resynchronization therapy with defibrillator (CRT-D)
CRT-D is indicated for HFrEF with LBBB and QRS ≥ 150 ms on optimal medical therapy to reduce mortality, hospitalization, and reverse remodel the LV.
When stratifying risk in patients with hypertrophic cardiomyopathy (HCM) for sudden cardiac death (SCD), which factor independently increases 5-year SCD risk?
Answer: Non-sustained ventricular tachycardia on Holter monitoring
Non-sustained VT on ambulatory monitoring is one of five major SCD risk factors in HCM used by the AHA/ESC HCM risk models to guide ICD implantation decisions.